The Effect of Depth of Anesthesia as Measured by Bispectral Index (BIS) on Emergence Agitation in Children
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether depth of anesthesia has an effect on emergence agitation (EA) in children age 2 - 8 years old. EA is a common problem in pediatric patients who receive general anesthesia with inhaled anesthetics, and the effect of depth of anesthesia on EA has not been studied. The study will randomize 40 children undergoing ophthalmologic surgery under general anesthesia to either light anesthesia (BIS 55-60) or deep anesthesia (BIS 40-45). EA will be measured by the peak Pediatric Assessment of Emergence Delirium (PAED) score in the recovery room, which rates agitation behaviors on a scale of 0 - 20. The hypothesis is that light anesthesia is associated with more EA.
| Condition | Intervention |
|---|---|
|
Emergence Agitation |
Other: Depth of anesthesia |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) |
| Official Title: | The Effect of Depth of Anesthesia as Measured by Bispectral Index (BIS) on Emergence Agitation in Children |
- Pediatric Assessment of Emergence Delirium score [ Time Frame: Within 30 minutes of arrival in recovery room ] [ Designated as safety issue: No ]
- Time to emergence from anesthesia [ Time Frame: After the completion of surgery ] [ Designated as safety issue: No ]
- RASS sedation score [ Time Frame: Within 30 minutes of arrival in recovery room ] [ Designated as safety issue: No ]
- Pain score (age appropriate - FLACC or FACES) [ Time Frame: Within 30 minutes of arrival in recovery room ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 50 |
| Study Start Date: | September 2009 |
| Estimated Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: High-normal BIS
Depth of anesthesia is titrated to a BIS of 55-60
|
Other: Depth of anesthesia
The intervention in this study is the titration of the depth of anesthesia according to the BIS monitor, as maintained by a combination of routine anesthetic agents (nitrous oxide, sevoflurane, and fentanyl).
|
|
Experimental: Low-normal BIS
Depth of anesthesia is maintained at a BIS level of 40-45
|
Other: Depth of anesthesia
The intervention in this study is the titration of the depth of anesthesia according to the BIS monitor, as maintained by a combination of routine anesthetic agents (nitrous oxide, sevoflurane, and fentanyl).
|
Eligibility| Ages Eligible for Study: | 2 Years to 8 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children age 2 - 8 (inclusive) undergoing ophthalmologic surgery
- ASA physical status 1 or 2
Exclusion Criteria:
- Surgery precluding placement of BIS monitor
- Non-English speaking, until additional language consent forms are approved
- Previous history of severe emergence agitation
Contacts and Locations| Contact: Heather J Frederick, MD | 919-812-6204 | heather.frederick@duke.edu |
| United States, North Carolina | |
| Duke University Medical Center - Eye Center | Recruiting |
| Durham, North Carolina, United States, 27710 | |
| Principal Investigator: | Heather J Frederick, MD | Duke University |
More Information
No publications provided
| Responsible Party: | Heather Frederick, Duke University Medical Center |
| ClinicalTrials.gov Identifier: | NCT00990769 History of Changes |
| Other Study ID Numbers: | Pro00015531 |
| Study First Received: | October 5, 2009 |
| Last Updated: | May 25, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Duke University:
|
Emergence delirium Bispectral Index Depth of anesthesia |
Additional relevant MeSH terms:
|
Psychomotor Agitation Dyskinesias Neurologic Manifestations Nervous System Diseases Psychomotor Disorders Neurobehavioral Manifestations Signs and Symptoms |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 23, 2013